Clinical Trial Update: Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis [NA]

View source ↗

Summary

A clinical trial evaluating azithromycin for management of acute exacerbation in idiopathic pulmonary fibrosis, currently recruiting at Assiut University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Assiut University | Conditions: Idiopathic Pulmonary Fibrosis | NA | Status: RECRUITING